Lobbying Relationship

Client

Novo Nordisk, Inc.

More records

Lobbying firm

Arnold & Porter Kaye Scholer LLP

More records

  • Issues related to pharmacy benefit managers and the 340B Program.
  • Issues related to pharmacy benefit managers and the 340B program. Issues related to the clinical and overall benefit of anti-obesity medications.
  • Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2023 (H.R. 4818 / S. 2407).

Duration: to

General Issues: Pharmacy, Health Issues, Medicare/Medicaid

Spending: about $280,000 (But it's complicated. Here's why.)

Agencies lobbied since 2023: House of Representatives, U.S. Senate, White House Office, Health & Human Services - Dept of (HHS)

Related Foreign Entities: Novo Holdings A/S (Gentofte Kommune, DEN); contribution to lobbying: $0; ownership 28%; Novo Nordisk Fonden (Gentofte Kommune, DEN); contribution to lobbying: $0; ownership 28%; Novo Nordisk A/S (Gladsaxe Kommune, DEN); contribution to lobbying: $0; ownership 100%

Bills mentioned

H.R.4818: Treat and Reduce Obesity Act of 2023

Sponsor: Brad Wenstrup (R-Ohio)

S.2407: Treat and Reduce Obesity Act of 2023

Sponsor: Thomas R. Carper (D-Del.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Eugenia Edwards Pierson Clerk, House Energy and Commerce Committee (2001-05)
Bobby McMillin General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-2013); Press Intern, Sen. Chambliss (2007)
Sonja Nesbit Deputy Assistant Secretary of Legislation, U.S. Dept. of Health & Human Services (2013-2016); Deputy Staff Director, Ways and Means Committee, Subcommittee on Income Security and Family Support, U.S. House of Representatives (2002-2013)
David Skillman Deputy Chief of Staff and Counsel, Rep. Blumenauer (2007-2019)
Casey Brouhard Health Counsel, Rep. Burgess (2019-2020); Intern, House Energy & Commerce Committee (2019)
Mickayla Stogsdill Intern, Senate Health, Education, Labor, and Pensions Committee (2018)
Peter Duyshart Program Support Student Trainee, Secretarial Internship Program, U.S. DOT (2020); Intern, Rep. Karen Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015)
Luke Albert Intern, Rep. Kendra Horn (2019)
Ron Kind Member of Congress, U.S. House of Representatives (1997-2023)

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page